PICOGEN: Five years experience with a genetic counselling program for dementia;PICOGEN: experiencia de 5 años de un programa de asesoramiento genético en demencia

Neurologia

Volumn 26, Issue 3, 2011, Pages 143-149

  Fortea, J ^a   Llado A ^a   Clarimon J ^b   Lleo A ^b   Oliva, R ^a   Peri, J ^a   Pintor, L ^a   Yague J ^a   Blesa, R ^b   Molinuevo, J L ^a   Sanchez Valle R ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b HOSPITAL DE LA SANTA CREU I SANT PAU   (Spain)

Author keywords

Alzheimer disease; Familial dementia; Frontotemporal lobar degeneration; Genetic counselling; Genetic screening; Prion diseases

Indexed keywords

ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; DEMENTIA; FAMILIAL DISEASE; FAMILY HISTORY; FOLLOW UP; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENETIC COUNSELING; GENETIC SCREENING; HUMAN; MAJOR CLINICAL STUDY; PHENOTYPE; RISK;

ADULT; AGED; AGED, 80 AND OVER; DEMENTIA; GENETIC COUNSELING; HUMANS; MIDDLE AGED; PROGRAM EVALUATION; TIME FACTORS;

EID: 79952739268     PISSN: 02134853     EISSN: 15781968     Source Type: Journal    
DOI: 10.1016/j.nrl.2010.09.011     Document Type: Article

References (29)

1. Lladó A., Gaig C., Molinuevo J.L. Genética de las enfermedades neurodegenerativas más prevalentes. Med Clin. 2006, 126(17):662-670.
2. Lleó A., Blesa R., Queralt R., Ezquerra M., Molinuevo J.L., Peña-Casanova J., et al. Frequency of mutations in the presenilin and amyloid precursor protein genes in early-onset Alzheimer disease in Spain. Arch Neurol. 2002, 59(11):1759-1763.
3. Kovács G.G., Puopolo M., Ladogana A., Pocchiari M., Budka H., van Duijn C., et al. Genetic prion disease: the EUROCJD experience. Hum Genet. 2005, 118(2):166-174.
4. Collins S.J., Lawson V.A., Masters C.L. Transmissible spongiform encephalopathies. Lancet. 2004, 363(9402):51-61.
5. Zarranz J.J., Digon A., Atarés B., Arteagoitia J.M., Carrera N., Fernández Manchola I., et al. Familial prion diseases in the Basque Country (Spain). Neuroepidemiology. 2005, 24(1-2):103-109.
6. Sánchez-Valle R., Nos C., Yagüe J., Graus F., Domínguez A., Saiz A. Clinical and genetic features of human prion diseases in Catalonia: 1993-2002. Eur J Neurol. 2004, 11(10):649-655. Catalan Collaborative Study Group for CJD.
7. Wiggins S., Whyte P., Huggins M., Adam S., Theilmann J., Bloch M., et al. The psychological consequences of predictive testing for Huntington's disease. Canadian Collaborative Study of Predictive Testing. N Engl J Med. 1992, 327(20):1401-1405.
8. Shepherd C., McCann H., Halliday G.M. Variations in the neuropathology of familial Alzheimer's disease. Acta Neuropathol. 2009, 118(1):37-52.
9. Liddell M.B., Lovestone S., Owen M.J. Genetic risk of Alzheimer's disease: advising relatives. Br J Psychiatry. 2001, 178:7-11.
10. Molinuevo J.L., Pintor L., Peri J.M., Lleó A., Oliva R., Marcos T., et al. Emotional reactions to predictive testing in Alzheimer's disease and other inherited dementias. Am J Alzheimers Dis Other Demen. 2005, 20(4):233-238.
11. Hayashi K., Yandell D.W. How sensitive is PCR-SSCP?. Hum Mutat. 1993, 2(5):338-346.
12. Guerreiro R.J., Baquero M., Blesa R., Boada M., Brás J.M., Bullido M.J., et al. Genetic screening of Alzheimer's disease genes in Iberian and African samples yields novel mutations in presenilins and APP. Neurobiol Aging 2010, 31(5):725-731.
13. Lladó A., Sánchez-Valle R., Rey M.J., Mercadal P., Almenar C., López-Villegas D., et al. New mutation in the PSEN1 (E120G) gene associated with early onset Alzheimer's disease. Neurologia. 2010, 25(1):13-16.
14. Queralt R., Ezquerra M., Castellví M., Lleó A., Blesa R., Oliva R. Detection of the presenilin 1 gene mutation (M139T) in early-onset familial Alzheimer disease in Spain. Neurosci Lett. 2001, 299(3):239-241.
15. Lladó A., Fortea J., Ojea T., Bosch B., Sanz P., Valls-Solé J., et al. A novel PSEN1 mutation (K239N) associated with Alzheimer's disease with wide range age of onset and slow progression. Eur J Neurol. 2010, 17(7):994-996.
16. Alzheimer disease and frontotemporal dementia mutation database. Disponible en: (consultado el 2 de diciembre de 2009). http://www.molgen.ua.ac.be/.
17. Sánchez-Valle R., Lladó A., Ezquerra M., Rey M.J., Rami L., Molinuevo J.L. A novel mutation in the PSEN1 gene (L286P) associated with familial early-onset dementia of Alzheimer type and lobar haematomas. Eur J Neurol. 2007, 14(12):1409-1412.
18. Aldudo J., Bullido M.J., Arbizu T., Oliva R., Valdivieso F. Identification of a novel mutation (Leu282Arg) of the human presenilin 1 gene in Alzheimer's disease. Neurosci Lett. 1998, 240(3):174-176.
19. Ezquerra M., Lleó A., Castellví M., Queralt R., Santacruz P., Pastor P., et al. A novel mutation in the PSEN2 gene (T430M) associated with variable expression in a family with early-onset Alzheimer disease. Arch Neurol. 2003, 60(8):1149-1151.
20. Sánchez-Valle R., Aróstegui J.I., Yagüe J., Rami L., Lladó A., Molinuevo J.L. First demonstrated de novo insertion in the prion protein gene in a young patient with dementia. J Neurol Neurosurg Psychiatry. 2008, 79(7):845-846.
21. Waldemar G., Dubois B., Emre M., Georges J., McKeith I.G., Rossor M., et al. EFNS. Recommendations for the diagnosis and management of Alzheimer's disease and other disorders associated with dementia: EFNS guideline. Eur J Neurol. 2007, 14(1):e1-26.
22. Rice D.P., Fillit H.M., Max W., Knopman D.S., Lloyd J.R., Duttagupta S., et al. Prevalence, costs, and treatment of Alzheimer's disease and related dementia: a managed care perspective. Am J Manag Care. 2001, 7(8):809-818.
23. Kowalska A. [Genetic counseling and testing for families with Alzheimer's disease]. Neurol Neurochir Pol. 2004, 38(6):495-501.
24. Raux G., Guyant-Maréchal L., Martin C., Bou J., Penet C., Brice A., et al. Molecular diagnosis of autosomal dominant early onset Alzheimer's disease: an update. J Med Genet. 2005, 42(10):793-795.
25. Seelaar H., Kamphorst W., Rosso S.M., Azmani A., Masdjedi R., de Koning I., et al. Distinct genetic forms of frontotemporal dementia. Neurology. 2008, 71(16):1220-1226.
26. Laccone F., Engel U., Holinski-Feder E., Weigell-Weber M., Marczinek K., Nolte D., et al. DNA analysis of Huntington's disease: five years of experience in Germany, Austria, and Switzerland. Neurology. 1999, 53(4):801-806.
27. Steinbart E.J., Smith C.O., Poorkaj P., Bird T.D. Impact of DNA testing for early-onset familial Alzheimer disease and frontotemporal dementia. Arch Neurol. 2001, 58(11):1828-1831.
28. Riedijk S.R., Niermeijer M.F., Dooijes D., Tibben A. A Decade of Genetic Counseling in Frontotemporal Dementia Affected Families: Few Counseling Requests and much Familial Opposition to Testing. J Genet Couns. 2009, 18(4):350-356.
29. Almqvist E.W., Bloch M., Brinkman R., Craufurd D., Hayden M.R. A Worldwide Assessment of the Frequency of Suicide. Suicide Attempts, or Psychiatric Hospitalization after Predictive Testing for HuntingtonDisease. Am. J Hum Genet. 1999, 64:1293-1304. on behalf of an international Huntington disease collaborative group.